 | • レポートコード：B-GIR08C5252 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：Medical Care |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、小分子標的癌療法の世界市場について調べ、まとめました。種類別セグメントは、モノクローナル抗体、小分子、小分子薬物コンジュゲート等、用途別セグメントは、等に区分しました。小分子標的癌療法の世界市場概観、企業動向、企業別小分子標的癌療法シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・小分子標的癌療法の市場概観 ・小分子標的癌療法の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・小分子標的癌療法の企業別販売動向、市場シェア、市場集中度、競争動向 ・小分子標的癌療法の世界市場規模 ・小分子標的癌療法の北米市場分析（アメリカ、カナダ、メキシコ等） ・小分子標的癌療法のアメリカ市場規模推移 ・小分子標的癌療法のカナダ市場規模推移 ・小分子標的癌療法のメキシコ市場規模推移 ・小分子標的癌療法のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・小分子標的癌療法のドイツ市場規模推移 ・小分子標的癌療法のイギリス市場規模推移 ・小分子標的癌療法のロシア市場規模推移 ・小分子標的癌療法のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・小分子標的癌療法の日本市場規模推移 ・小分子標的癌療法の中国市場規模推移 ・小分子標的癌療法の韓国市場規模推移 ・小分子標的癌療法のインド市場規模推移 ・小分子標的癌療法の東南アジア市場規模推移 ・小分子標的癌療法の南米市場分析（ブラジル、アルゼンチン等） ・小分子標的癌療法の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・小分子標的癌療法の種類別分析/販売量、売上、市場シェア（モノクローナル抗体、小分子、小分子薬物コンジュゲート） ・小分子標的癌療法の用途別分析/市場規模（） ・小分子標的癌療法の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・小分子標的癌療法の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Small Molecule Targeted Cancer Therapy market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Small Molecule Targeted Cancer Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Small Molecule Targeted Cancer Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Small Molecule Targeted Cancer Therapy market by product type and applications/end industries.
Market Segment by Companies, this report covers
OncoGenex Pharmaceuticals, Inc.
Cytokinetics Inc.
Hospira Inc.
GlaxoSmithKline plc
Boehringer Ingelheim GmbH
Bayer HealthCare AG
Abbott Laboratories
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal Antibodies
Small Molecules
Small Molecule Drug Conjugates
Market Segment by Applications, can be divided into
Lymphoma
Melanoma
Multiple Myeloma
Breast Cancer
Prostate Cancer
Other Cancers
Table of Contents
1 Small Molecule Targeted Cancer Therapy Market Overview
1.1 Product Overview and Scope of Small Molecule Targeted Cancer Therapy
1.2 Classification of Small Molecule Targeted Cancer Therapy by Types
1.2.1 Global Small Molecule Targeted Cancer Therapy Revenue Comparison by Types (2019-2024)
1.2.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Types in 2018
1.2.3 Monoclonal Antibodies
1.2.4 Small Molecules
1.2.5 Small Molecule Drug Conjugates
1.3 Global Small Molecule Targeted Cancer Therapy Market by Application
1.3.1 Global Small Molecule Targeted Cancer Therapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Lymphoma
1.3.3 Melanoma
1.3.4 Multiple Myeloma
1.3.5 Breast Cancer
1.3.6 Prostate Cancer
1.3.7 Other Cancers
1.4 Global Small Molecule Targeted Cancer Therapy Market by Regions
1.4.1 Global Small Molecule Targeted Cancer Therapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Small Molecule Targeted Cancer Therapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Small Molecule Targeted Cancer Therapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Small Molecule Targeted Cancer Therapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Small Molecule Targeted Cancer Therapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Small Molecule Targeted Cancer Therapy Status and Prospect (2014-2024)
1.5 Global Market Size of Small Molecule Targeted Cancer Therapy (2014-2024)
2 Manufacturers Profiles
2.1 OncoGenex Pharmaceuticals, Inc.
2.1.1 Business Overview
2.1.2 Small Molecule Targeted Cancer Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 Cytokinetics Inc.
2.2.1 Business Overview
2.2.2 Small Molecule Targeted Cancer Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 Hospira Inc.
2.3.1 Business Overview
2.3.2 Small Molecule Targeted Cancer Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 GlaxoSmithKline plc
2.4.1 Business Overview
2.4.2 Small Molecule Targeted Cancer Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 Boehringer Ingelheim GmbH
2.5.1 Business Overview
2.5.2 Small Molecule Targeted Cancer Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bayer HealthCare AG
2.6.1 Business Overview
2.6.2 Small Molecule Targeted Cancer Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
2.7 Abbott Laboratories
2.7.1 Business Overview
2.7.2 Small Molecule Targeted Cancer Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global Small Molecule Targeted Cancer Therapy Market Competition, by Players
3.1 Global Small Molecule Targeted Cancer Therapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Small Molecule Targeted Cancer Therapy Players Market Share
3.2.2 Top 10 Small Molecule Targeted Cancer Therapy Players Market Share
3.3 Market Competition Trend
4 Global Small Molecule Targeted Cancer Therapy Market Size by Regions
4.1 Global Small Molecule Targeted Cancer Therapy Revenue and Market Share by Regions
4.2 North America Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
4.3 Europe Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
4.5 South America Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
5 North America Small Molecule Targeted Cancer Therapy Revenue by Countries
5.1 North America Small Molecule Targeted Cancer Therapy Revenue by Countries (2014-2019)
5.2 USA Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
5.3 Canada Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
6 Europe Small Molecule Targeted Cancer Therapy Revenue by Countries
6.1 Europe Small Molecule Targeted Cancer Therapy Revenue by Countries (2014-2019)
6.2 Germany Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
6.3 UK Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
6.4 France Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
6.5 Russia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
6.6 Italy Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Countries
7.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue by Countries (2014-2019)
7.2 China Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
7.3 Japan Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
7.4 Korea Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
7.5 India Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
8 South America Small Molecule Targeted Cancer Therapy Revenue by Countries
8.1 South America Small Molecule Targeted Cancer Therapy Revenue by Countries (2014-2019)
8.2 Brazil Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Small Molecule Targeted Cancer Therapy by Countries
9.1 Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
9.3 UAE Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
10 Global Small Molecule Targeted Cancer Therapy Market Segment by Type
10.1 Global Small Molecule Targeted Cancer Therapy Revenue and Market Share by Type (2014-2019)
10.2 Global Small Molecule Targeted Cancer Therapy Market Forecast by Type (2019-2024)
10.3 Monoclonal Antibodies Revenue Growth Rate (2014-2024)
10.4 Small Molecules Revenue Growth Rate (2014-2024)
10.5 Small Molecule Drug Conjugates Revenue Growth Rate (2014-2024)
11 Global Small Molecule Targeted Cancer Therapy Market Segment by Application
11.1 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Application (2014-2019)
11.2 Small Molecule Targeted Cancer Therapy Market Forecast by Application (2019-2024)
11.3 Lymphoma Revenue Growth (2014-2019)
11.4 Melanoma Revenue Growth (2014-2019)
11.5 Multiple Myeloma Revenue Growth (2014-2019)
11.6 Breast Cancer Revenue Growth (2014-2019)
11.7 Prostate Cancer Revenue Growth (2014-2019)
11.8 Other Cancers Revenue Growth (2014-2019)
12 Global Small Molecule Targeted Cancer Therapy Market Size Forecast (2019-2024)
12.1 Global Small Molecule Targeted Cancer Therapy Market Size Forecast (2019-2024)
12.2 Global Small Molecule Targeted Cancer Therapy Market Forecast by Regions (2019-2024)
12.3 North America Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)
12.4 Europe Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)
12.6 South America Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Small Molecule Targeted Cancer Therapy Picture
Table Product Specifications of Small Molecule Targeted Cancer Therapy
Table Global Small Molecule Targeted Cancer Therapy and Revenue (Million USD) Market Split by Product Type
Figure Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Types in 2018
Figure Monoclonal Antibodies Picture
Figure Small Molecules Picture
Figure Small Molecule Drug Conjugates Picture
Table Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) by Application (2014-2024)
Figure Small Molecule Targeted Cancer Therapy Revenue Market Share by Applications in 2018
Figure Lymphoma Picture
Figure Melanoma Picture
Figure Multiple Myeloma Picture
Figure Breast Cancer Picture
Figure Prostate Cancer Picture
Figure Other Cancers Picture
Table Global Market Small Molecule Targeted Cancer Therapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate (2014-2024)
Table OncoGenex Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Type and Applications
Table OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Cytokinetics Inc. Basic Information, Manufacturing Base and Competitors
Table Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Type and Applications
Table Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Hospira Inc. Basic Information, Manufacturing Base and Competitors
Table Hospira Inc. Small Molecule Targeted Cancer Therapy Type and Applications
Table Hospira Inc. Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Type and Applications
Table GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Type and Applications
Table Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer HealthCare AG Basic Information, Manufacturing Base and Competitors
Table Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Type and Applications
Table Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Small Molecule Targeted Cancer Therapy Type and Applications
Table Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) by Players (2014-2019)
Table Global Small Molecule Targeted Cancer Therapy Revenue Share by Players (2014-2019)
Figure Global Small Molecule Targeted Cancer Therapy Revenue Share by Players in 2017
Figure Global Small Molecule Targeted Cancer Therapy Revenue Share by Players in 2018
Figure Global Top 5 Players Small Molecule Targeted Cancer Therapy Revenue Market Share in 2018
Figure Global Top 10 Players Small Molecule Targeted Cancer Therapy Revenue Market Share in 2018
Figure Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) by Regions (2014-2019)
Table Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Regions (2014-2019)
Figure Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Regions in 2018
Figure North America Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Europe Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure South America Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Table North America Small Molecule Targeted Cancer Therapy Revenue by Countries (2014-2019)
Table North America Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure North America Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries in 2018
Figure USA Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Canada Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Mexico Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Table Europe Small Molecule Targeted Cancer Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure Europe Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries in 2018
Figure Germany Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure UK Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure France Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Russia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Italy Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries in 2018
Figure China Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Japan Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Korea Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure India Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Table South America Small Molecule Targeted Cancer Therapy Revenue by Countries (2014-2019)
Table South America Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure South America Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries in 2018
Figure Brazil Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Argentina Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Colombia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure UAE Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Egypt Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Figure South Africa Small Molecule Targeted Cancer Therapy Revenue and Growth Rate (2014-2019)
Table Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) by Type (2014-2019)
Table Global Small Molecule Targeted Cancer Therapy Revenue Share by Type (2014-2019)
Figure Global Small Molecule Targeted Cancer Therapy Revenue Share by Type (2014-2019)
Figure Global Small Molecule Targeted Cancer Therapy Revenue Share by Type in 2019
Table Global Small Molecule Targeted Cancer Therapy Revenue Forecast by Type (2019-2024)
Figure Global Small Molecule Targeted Cancer Therapy Market Share Forecast by Type (2019-2024)
Figure Global Monoclonal Antibodies Revenue Growth Rate (2014-2019)
Figure Global Small Molecules Revenue Growth Rate (2014-2019)
Figure Global Small Molecule Drug Conjugates Revenue Growth Rate (2014-2019)
Table Global Small Molecule Targeted Cancer Therapy Revenue by Application (2014-2019)
Table Global Small Molecule Targeted Cancer Therapy Revenue Share by Application (2014-2019)
Figure Global Small Molecule Targeted Cancer Therapy Revenue Share by Application (2014-2019)
Figure Global Small Molecule Targeted Cancer Therapy Revenue Share by Application in 2019
Table Global Small Molecule Targeted Cancer Therapy Revenue Forecast by Application (2019-2024)
Figure Global Small Molecule Targeted Cancer Therapy Market Share Forecast by Application (2019-2024)
Figure Global Lymphoma Revenue Growth Rate (2014-2019)
Figure Global Melanoma Revenue Growth Rate (2014-2019)
Figure Global Multiple Myeloma Revenue Growth Rate (2014-2019)
Figure Global Breast Cancer Revenue Growth Rate (2014-2019)
Figure Global Prostate Cancer Revenue Growth Rate (2014-2019)
Figure Global Other Cancers Revenue Growth Rate (2014-2019)
Figure Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Small Molecule Targeted Cancer Therapy Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Small Molecule Targeted Cancer Therapy Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)
Figure Europe Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)
Figure South America Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Market Forecast (2019-2024)
小分子癌治療薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Small Molecule Cancer Drug is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Small Molecule Cancer …- 世界の小分子創薬市場：市場規模・現状・予測 In 2018, the global Small-Molecule Drug Discovery market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Small-Molecule Drug Discovery status, future forecast, growth opportunity, key market…
- がん標的療法の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Cancer Targeted Therapy market is valued at million USD in 2018 and is expected to reach million USD by the end of 2024, growing at a CAGR of between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast g…
- 小分子活性医薬成分の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Small Molecule Active Pharmaceutical Ingredient is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the S…
- 乳癌用HER-2標的薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global HER-2 Targeted Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especia…